Blurred vision "in a tunnel"; Blurred vision "in a tunnel"; Difficulty walking; Dizzy; Tingling in face and mouth; Face felt flushed; Chills; Nauseas; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TUNNEL VISION (Blurred vision "in a tunnel") in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), AMPHETAMINE, EPINEPHRINE, AMLODIPINE, NIMODIPINE and ALPRAZOLAM for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced TUNNEL VISION (Blurred vision "in a tunnel") (seriousness criterion medically significant), VISION BLURRED (Blurred vision "in a tunnel"), GAIT DISTURBANCE (Difficulty walking), DIZZINESS (Dizzy), PARAESTHESIA (Tingling in face and mouth), FLUSHING (Face felt flushed), CHILLS (Chills) and NAUSEA (Nauseas). At the time of the report, TUNNEL VISION (Blurred vision "in a tunnel"), VISION BLURRED (Blurred vision "in a tunnel"), GAIT DISTURBANCE (Difficulty walking), DIZZINESS (Dizzy), PARAESTHESIA (Tingling in face and mouth), FLUSHING (Face felt flushed), CHILLS (Chills) and NAUSEA (Nauseas) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, COVID-19: positive (Positive) other. On 22-Feb-2021, COVID-19: negative (Negative) other.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       A few minutes after vaccine administration, the patient became dizzy, nausea, blurred vision "in a tunnel", chills, difficulty walking and tingling in face and mouth. Her face also felt flushed at the time. The patient was then transported by Ambulance to the Emergency Room. At the Emergency Room the patient was treated and discharged. The side effects have improved, but are still present at this time.  Treatment medications included lorazepam and ondansetron.  Company comment: This case concerns a 35-year-old female with PMH of COVID-19 a serious unexpected event of tunnel vision, and non serious unexpected vision blurred, gait disturbance, dizziness, paresthesia, flushing, and expected chills and nausea. Event onset the same day as first dose mRNA-1273. Events resolving. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 35-year-old female with PMH of COVID-19 a serious unexpected event of tunnel vision, and nonserious unexpected vision blurred, gait disturbance, dizziness, paraesthesia, flushing, and expected chills and nausea. Event onset the same day as first dose mRNA-1273. Events resolving. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.